Literature DB >> 30848337

Mid-term outcomes of individualized surgeries in patients with Ebstein's anomaly.

Jiaquan Zhu1, Li Zhang1, Chunrong Bao1, Fangjie Xu1, Fangbao Ding1, Ju Mei2.   

Abstract

The variable anatomy of Ebstein's anomaly leads to its various surgical procedures. The long-term outcomes of different operations were not well established. Thirty-five patients with Ebstein's anomaly who underwent operations from 2006 to 2018 in our department were retrospectively reviewed. Individualized surgical plans were performed according to the preoperative echocardiography and surgeons' preference. Tricuspid repair, either Danielson's or Carpentier's technique, was the primary choice in patients who had sufficient tricuspid leaflets and adequate right ventricle, while tricuspid replacement was used when a reliable repair is not achievable. Additional bidirectional cavopulmonary shunt was performed in those who had unstable hemodynamics despite of high central venous pressure after separation from cardiopulmonary bypass. The perioperative and follow-up data were collected. The age was 26.9 (0.6-54) years [16 children (age < 14, and 19 adults (age ≥ 14)]. Preoperative tricuspid regurgitation was severe in 30, moderate in 4, and mild in the remaining 1 patient. Preoperative cardiac-associated malformations include 20 atrial septal defects, 2 ventricular septal defects, 2 pulmonary stenosis, and 1 sub aortic ridge, and these were operated simultaneously. Among all the surgical patients, 2 needed additional reoperation during the same admission, and ultimately, 29 patients had biventricular repair, including 21 tricuspid repair and 8 replacements. The other 6 patients had cavopulmonary connection and achieved 1.5 ventricular repair (3 tricuspid repair and 3 replacements). In all the 24 tricuspid repair patients, Danielson's procedure was used in 17, while Carpentier's technique was used in the other 7 patients. The average cardiopulmonary bypass time was 90 ± 28 min and cross-clamp time was 48 ± 24min. There were 2 perioperative deaths (5.7%) and no third-degree atrioventricular block. The postoperative in hospital stay was 13.7 ± 9.6 days. In the 33 survivors who were followed up at a median of 29.2 months, 6 patients had severe tricuspid regurgitation, and 2 of them underwent tricuspid replacement. The 5-year freedom from severe tricuspid dysfunction or reoperation was 78.5%, and no difference was found between children and adults, neither between different surgical choices. The surgeries of Ebstein's anomaly were variable, and individualized operation achieved reasonable short- and mid-term results. However, severe tricuspid regurgitation during the follow-up was not neglectable, and reoperation in such cases also achieved good outcomes. New repair strategy such as cone repair may be considered.

Entities:  

Keywords:  Congenital heart disease; Ebstein’s anomaly; Surgery

Mesh:

Year:  2019        PMID: 30848337     DOI: 10.1007/s00380-019-01358-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  41 in total

1.  Anatomic correction of Ebstein anomaly.

Authors:  Q Wu; Z Huang
Journal:  J Thorac Cardiovasc Surg       Date:  2001-12       Impact factor: 5.209

2.  A new procedure for Ebstein's anomaly.

Authors:  Qingyu Wu; Zhixiong Huang
Journal:  Ann Thorac Surg       Date:  2004-02       Impact factor: 4.330

3.  Ebstein's anomaly: repair based on functional analysis.

Authors:  S Chauvaud; A Berrebi; N d'Attellis; E Mousseaux; A Hernigou; A Carpentier
Journal:  Eur J Cardiothorac Surg       Date:  2003-04       Impact factor: 4.191

4.  Outcome in neonates with Ebstein's anomaly.

Authors:  D S Celermajer; S Cullen; I D Sullivan; D J Spiegelhalter; R K Wyse; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1992-04       Impact factor: 24.094

5.  Results of surgery for Ebstein anomaly: a multicenter study from the European Congenital Heart Surgeons Association.

Authors:  George E Sarris; Nikos M Giannopoulos; Alexander J Tsoutsinos; Andreas K Chatzis; George Kirvassilis; William J Brawn; Juan V Comas; Antonio F Corno; Duccio Di Carlo; Josè Fragata; Victor Hraska; Jeffrey P Jacobs; Sofia Krupianko; Heikki Sairanen; Giovanni Stellin; Andreas Urban; Gerhard Ziemer
Journal:  J Thorac Cardiovasc Surg       Date:  2006-06-02       Impact factor: 5.209

6.  Surgical management of Ebstein's anomaly in the adult.

Authors:  Joseph A Dearani; Gordon K Danielson
Journal:  Semin Thorac Cardiovasc Surg       Date:  2005

7.  Neonatal repair of Ebstein's anomaly: indications, surgical technique, and medium-term follow-up.

Authors:  C J Knott-Craig; E D Overholt; K E Ward; J D Razook
Journal:  Ann Thorac Surg       Date:  2000-05       Impact factor: 4.330

8.  [Ebstein's anomaly: results of the conic reconstruction of the tricuspid valve].

Authors:  José Pedro da Silva; José Francisco Baumgratz; Luciana da Fonseca; Jorge Yussef Afiune; Sônia Meiken Franchi; Lílian Maria Lopes; Daniel Marcelo Silva Magalhães; José Henrique Andrade Vila
Journal:  Arq Bras Cardiol       Date:  2004-04-05       Impact factor: 2.000

9.  Early and medium-term results for repair of Ebstein anomaly.

Authors:  Jonathan M Chen; Ralph S Mosca; Karen Altmann; Beth F Printz; Kimara Targoff; Pamela A Mazzeo; Jan M Quaegebeur
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

10.  Operative treatment of Ebstein's anomaly.

Authors:  G K Danielson; D J Driscoll; D D Mair; C A Warnes; W C Oliver
Journal:  J Thorac Cardiovasc Surg       Date:  1992-11       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.